Navigation Links
Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors
Date:2/6/2012

of Sciences (USA), a Foreign Associate of the American Academy of Arts and Sciences, as well as a Fellow of the Royal Society of London (UK). He was recently awarded the Order of Ontario and has won international recognition in the form of the Emil von Behring Prize, the King Faisal Prize for Medicine, the Gairdner Foundation International Award, the Sloan Prize of the General Motors Cancer Foundation, the Novartis Prize in Immunology and the Paul Ehrlich Prize and Ludwig Darmstaedter Prize of Germany. Dr. Mak's held the position of VP of Research at Amgen, Inc. and was Director of the Amgen Institute in Toronto from 1993-2002. His experience as a venture capitalist allows him to be an integral part of start-up companies.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission (the SEC).

About ENMD-2076

ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers. ENMD-2076 also targets the VEGFR, Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers. ENMD-2076 has shown promising activity in Phase 1 clinical trials in solid tumor cancers, leukemia, and multiple myeloma.&
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. European Pharmaceutical and Biotech Contract Manufacturing Markets
2. Biotechnology Pharmaceutical Company Selects NewCardios QTinno for Thorough QT Trial
3. Leaders of Healthcare, Biotech and Pharmaceutical Companies Sending Proclamation to President Obama and Congress Urging Solution to Nations Healthcare Crisis
4. Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation
5. Lixte Biotechnology Holdings Announces Issuance of U.S. Patent for Agents for the Treatment of Neurodegenerative Diseases
6. GenturaDx to Present at the Biotech Showcase Conference
7. Inovio Pharmaceuticals to Present at Biotech Showcase Investor Conference
8. Trinity Biotech to Present at Sidoti & Companys Semiannual New York Micro-Cap Conference on January 9, 2012
9. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
10. Ikaria® to Present at Biotech Showcase™ 2012
11. Express Scripts HealthBridge Pharma & Biotech to Provide Specialty Pharmacy and Specialty Distribution Services for EYLEA™ (aflibercept) Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Pa. , July 23, 2014 /PRNewswire/ ... today announced successful results from its randomized, ... in women with biopsy-proven cervical intraepithelial neoplasia ... types 16 or 18. Treatment with VGX-3100, ... of CIN2/3 to CIN1 or no disease, ...
(Date:7/23/2014)... , July 23, 2014  Nearly 8,000 attendees will ... Cardinal Health,s annual Retail Business Conference (RBC), taking place ... Center. This year,s event encourages pharmacists to "Lead Change" ... communities and for their future. ... to network with their peers and learn new ways ...
(Date:7/23/2014)... 23, 2014  Mevesi Inc. would like to ... integration provides pharmacies with the ability to send ... patients. Mevesi,s solutions provide an ... to define target marketing campaigns. This coupled with ... within the Digital Marketing, Population Management, and Pharmacy ...
Breaking Medicine Technology:Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6Mevesi Enhances Solutions with Variable Print Media Capabilities! 2
... LOUIS, Jan. 11, 2011 Stereotaxis, Inc. (Nasdaq: ... procedure with the Vdrive™ robotic navigation system as the ...   In the first procedure with the ... of Clinical Electrophysiology at the Erasmus Medical Center in ...
... Mich., Jan. 10, 2011 Stryker Corporation (NYSE: ... for the fourth quarter of 2010, representing an 8.8% increase ... of 2009, and were $7,320 million for the year ended ... of $6,723 million for the year ended December 31, 2009. ...
Cached Medicine Technology:Stereotaxis Announces CE Mark and First Human Case for Vdrive™ 2Stereotaxis Announces CE Mark and First Human Case for Vdrive™ 3Stryker Increases Expected 2010 Results and Provides 2011 Outlook 2Stryker Increases Expected 2010 Results and Provides 2011 Outlook 3Stryker Increases Expected 2010 Results and Provides 2011 Outlook 4Stryker Increases Expected 2010 Results and Provides 2011 Outlook 5Stryker Increases Expected 2010 Results and Provides 2011 Outlook 6Stryker Increases Expected 2010 Results and Provides 2011 Outlook 7
(Date:7/23/2014)... Texas Physical Therapy Specialists (TexPTS) is proud to ... Liberty Hill, Parmer, Balcones, and Georgetown clinics have received ... Certified Specialist (OCS) or Sports Certified Specialist ... Tony Lauretta, PT, DPT, OCS, Jason Brown, PT, DPT, ... DPT, OCS, and Mary Grimberg, PT, DPT, OCS received ...
(Date:7/23/2014)... the likelihood of forming false memories, according to research ... the Association for Psychological Science. , In a study ... University of California, Irvine and colleagues, sleep-deprived people who ... read false information about the photos were more likely ... than were those who got a full night,s sleep. ...
(Date:7/23/2014)... CarePoint Health is proud to announce ... Jersey to receive the da Vinci® Xi™ Surgical System, ... da Vinci series. This 4th generation robotic platform is ... innovation. The intuitive da Vinci Xi has broad capabilities ... minimally invasive and complex surgical procedures. The acquisition of ...
(Date:7/23/2014)... The North American market was valued at $985.4 million ... CAGR of 10.79%, to reach $1,801.1 million by 2018. Organobromines ... North American Bromine Market report defines and segments the bromine ... Browse through the TOC of the North American Bromine Market ... This also provides a glimpse of the segmentation in the ...
(Date:7/23/2014)... Recently, Agebc.com has launched its new ... is announcing a promotion of wedding dresses. According to ... at the end of this month. , The beautiful ... like A-line, mermaid, ball-gown, empire, and more. Agebc.com is ... special-occasion dresses for women, and the company is devoted ...
Breaking Medicine News(10 mins):Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3Health News:Sleep deprivation may increase susceptibility to false memories 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 3Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 4Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 4Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2
... Bird, a molecular geneticist at the University of Edinburgh, Scotland, ... of a protein called Uqcrc1 in the brains of mouse ... which are the powerhouses of the cells to work overtime. ... mitochondrial gene has been linked to Rett Syndrome. The co-author ...
... that the male survivors of childhood sexual abuse ... understood// many health care practitioners as well as ... male and female childhood sexual survivors usually exhibit ... encounters with health care professionals, there are gender ...
... that New Orleans seems to be going throuogh a ... intensity rarely seen in the US. ,Suicide ... struck, 10 months ago. To make matters worse the ... the police department to deal with the large number ...
... University and the Celiac Sprue Research Foundation have claimed ... celiac sprue// that is an inherited inflammatory disorder of ... around the world. The two research studies that have ... Biology have opened the way for clinical testing with ...
... Cadbury Ireland had on the 23rd June recalled almost ... move because there are fears// that those bars may ... the company has said that there were minute traces ... levels that stipulated by the scientific standards for any ...
... to use a protein that has been originally isolated from ... genetically// modified technology. ,The parent company, Unilever, have ... ice creams that are of low-calorie, and low fat. They ... newer versions of their best selling products like the Cornetto, ...
Cached Medicine News:Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 2Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 3Health News:Sexually Abused Males Found Struggling In heir relations with Healthcare Providers 2Health News:Scientists Discover Non-dietary Therapy For Celiac Diseases 2Health News:Wall's To Develop Low-fat Ice-cream Using Fish Blood 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: